Amgen (AMGN) insider plans Rule 144 sale of option-exercise shares

Rhea-AI Filing Summary

Amgen Inc. insider(s) filed to sell common stock under Rule 144. The planned sales relate to shares acquired through cashless stock option exercises dated April 27, 2018 and May 3, 2019. Proposed sales for cash are expected on or after August 6, 2026, with the stock listed on NASDAQ and Raymond James & Associates involved as broker.

Key Figures

Shares from 2018 option exercise: 1,970 shares Shares from 2019 option exercise: 1,000 shares Planned sale date: 08/06/2026

3 metrics

Shares from 2018 option exercise 1,970 shares Common stock from cashless stock option exercise on 04/27/2018

Shares from 2019 option exercise 1,000 shares Common stock from cashless stock option exercise on 05/03/2019

Planned sale date 08/06/2026 Date associated with proposed cash sales of common stock

Key Terms

Rule 144, Cashless Stock Option Exercise, Common

3 terms

Rule 144 regulatory

"Amgen Inc. insider(s) filed to sell common stock under Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Cashless Stock Option Exercise financial

"Common | 04/27/2018 | Cashless Stock Option Exercise | Issuer"

Common financial

"144: Securities Information Common | Raymond James & Associates"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/06/2026 - 02:14 PM Accepted by SEC EDGAR 08/06/2026 - 02:13 PM Learn about SEC filing dates

FAQ

What does Amgen (AMGN) disclose in this Form 144 filing?

The filing discloses a proposed sale of Amgen common stock under Rule 144, involving shares acquired through cashless stock option exercises that are planned to be sold for cash through a broker.

How many Amgen (AMGN) shares are linked to the stock option exercises?

The filing lists 1,970 shares from a cashless stock option exercise on April 27, 2018 and 1,000 shares from a similar exercise on May 3, 2019, both designated as common stock.

When are the Amgen (AMGN) shares expected to be sold under this Form 144?

The common shares obtained via the cashless option exercises are slated for potential sale for cash on or after August 6, 2026, consistent with the timetable disclosed in the Rule 144 notice.

What role does Raymond James play in the Amgen (AMGN) Form 144 transaction?

Raymond James & Associates, based in St. Petersburg, Florida, is listed in connection with the common stock to be sold, indicating its role as the broker handling the planned Rule 144 sales.

What type of transaction is used for the Amgen (AMGN) options in this Form 144?

The underlying shares were obtained via cashless stock option exercises, meaning options were exercised without a cash outlay, and the resulting common shares are now designated for potential sale for cash.

On which market are the Amgen (AMGN) shares in this Form 144 listed?

The common shares described in the Form 144 are listed on NASDAQ, as indicated in the securities information section describing the issuer’s common stock and trading market.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Raymond James & Associates 880 Carillon Parkway St. Petersburg FL 33716	2670	1193940.00	539000000	08/06/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	04/27/2018	Cashless Stock Option Exercise	Issuer			1970	08/06/2026	Cash
Common	05/03/2019	Cashless Stock Option Exercise	Issuer			1000	08/06/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)